Literature DB >> 1681743

Phospholamban mediates the beta-adrenergic-enhanced Ca2+ uptake in mammalian ventricular myocytes.

J S Sham1, L R Jones, M Morad.   

Abstract

To probe the molecular mechanism responsible for the relaxant effect of catecholamines in heart muscle, we studied the effect of a monoclonal antibody (2D12) against phospholamban in intact whole cell clamped guinea pig ventricular myocytes, in which intracellular Ca2+ transient and Ca2+ current were simultaneously measured. The antibody stimulated Ca2+ uptake in guinea pig ventricular sarcoplasmic reticular vesicles, shifting the apparent dissociation constant for activation by Ca2+ from 200 to 60 nM. The stimulatory effect of the antibody could be mimicked by the catalytic subunit of adenosine 3',5'-cyclic monophosphate-dependent kinase and could be blocked by phospholamban peptide 2-25. Dialysis of ventricular myocytes with the antibody enhanced the rate of uptake of Ca2+ and significantly suppressed the ability of isoproterenol to enhance the rate of uptake and release of Ca2+ by depolarizing pulses. These data suggest that not only is phosphorylation of phospholamban crucial in sequestration of Ca2+ by the sarcoplasmic reticulum, but that this process may account for the catecholamine-enhanced rate of Ca2+ uptake release in heart muscle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681743     DOI: 10.1152/ajpheart.1991.261.4.H1344

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  32 in total

1.  Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: new insights on Ca-ATPase regulation by phospholamban.

Authors:  J E Mahaney; J M Autry; L R Jones
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

Review 2.  Transcriptional regulation by cAMP in the heart.

Authors:  F U Müller; J Neumann; W Schmitz
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

3.  Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy.

Authors:  H S Young; L R Jones; D L Stokes
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

4.  An autoinhibitory peptide from the erythrocyte Ca-ATPase aggregates and inhibits both muscle Ca-ATPase isoforms.

Authors:  L G Reddy; Y Shi; H Kutchai; A G Filoteo; J T Penniston; D D Thomas
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

5.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

6.  Sarcoplasmic reticulum calcium load regulates rat arterial smooth muscle calcium sparks and transient K(Ca) currents.

Authors:  Serguei Y Cheranov; Jonathan H Jaggar
Journal:  J Physiol       Date:  2002-10-01       Impact factor: 5.182

7.  Characterizing phospholamban to sarco(endo)plasmic reticulum Ca2+-ATPase 2a (SERCA2a) protein binding interactions in human cardiac sarcoplasmic reticulum vesicles using chemical cross-linking.

Authors:  Brandy L Akin; Larry R Jones
Journal:  J Biol Chem       Date:  2012-01-14       Impact factor: 5.157

8.  An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban.

Authors:  G Hughes; A P Starling; R P Sharma; J M East; A G Lee
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

9.  Anesthetics alter the physical and functional properties of the Ca-ATPase in cardiac sarcoplasmic reticulum.

Authors:  B S Karon; L M Geddis; H Kutchai; D D Thomas
Journal:  Biophys J       Date:  1995-03       Impact factor: 4.033

10.  Translation of Ser16 and Thr17 phosphorylation of phospholamban into Ca 2+-pump stimulation.

Authors:  W A Jackson; J Colyer
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.